Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Moodys
Dow
Johnson and Johnson
AstraZeneca

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for HUMANA INC. v. CELGENE CORPORATION (D.N.J. 2019)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

HUMANA INC. v. CELGENE CORPORATION (D.N.J. 2019)

Docket   Start Trial Date Filed 2019-03-01
Court District Court, D. New Jersey Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Esther Salas
Jury Demand Plaintiff Referred To Michael A. Hammer
Parties CELGENE CORPORATION; HUMANA INC.
Patents 6,045,501; 6,315,720; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 6,908,432; 7,141,018; 7,189,740; 7,230,012; 7,435,745; 7,465,800; 7,468,363; 7,668,730; 7,855,217; 7,874,984; 7,959,566; 7,968,569; 8,204,763; 8,315,886; 8,404,717; 8,530,498; 8,589,188; 8,626,531; 8,648,095; 8,741,929; 9,056,120; 9,101,621; 9,101,622
Attorneys ANTHONY MICHAEL CHRISTINA; DANIEL RENE GUADALUPE; PETER D. ST. PHILLIP , JR.; URIEL RABINOVITZ
Firms Lowey Dannenberg P.C.; NORRIS, McLAUGHLIN & MARCUS, PC
Link to Docket External link to docket
Small Molecule Drugs cited in HUMANA INC. v. CELGENE CORPORATION
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in HUMANA INC. v. CELGENE CORPORATION

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for HUMANA INC. v. CELGENE CORPORATION (D.N.J. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Complaint preventing the Revlimid ‘501 Patent 6,045,501 4-Apr-00 …800 patent, ‘217 patent, ‘569 patent, ‘498 patent, ‘095 patent, ‘621 patent, and the ‘622 patent. 92 …800 patent, ‘217 patent, ‘569 patent, ‘498 patent, ‘095 patent, ‘621 patent, and the ‘622 patent. 93 …‘501 patent, the ‘976 patent, the ‘432 patent, the ‘984 patent, the ‘763 patent, the ‘188 patent, the …‘720 patent, the ‘977 patent, the ‘784 patent, the ‘399 patent, the ‘018 patent, the ‘566 patent, the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Baxter
Express Scripts
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.